Physician profile
Kelli Brown
NPI 1275853533
$507.40
in general payments reported to CMS, 2019-2025
14 companies · $14.90 in 2025
The $14.90 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $124 · 2020: $60.24 · 2021: $51.51 · 2022: $182 · 2023: $14.43 · 2024: $60.45 · 2025: $14.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $89.78.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $89.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $86.49 | 2022-2025 | Xifaxan |
| Glaxosmithkline, LLC. | $86.28 | 2019-2024 | Bexsero |
| Daiichi Sankyo INC. | $73.75 | 2021-2022 | |
| Ironshore Pharmaceuticals INC. | $51.63 | 2019 | |
| Novo Nordisk INC | $35.14 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $30.04 | 2020 | |
| Merck Sharp & Dohme LLC | $24.75 | 2020-2022 | |
| Coloplast Corp | $22.68 | 2019 | |
| Sunovion Pharmaceuticals INC. | $20.91 | 2019 | |
| Vanda Pharmaceuticals INC. | $16.40 | 2024 | Fanapt, Hetlioz |
| Kowa Pharmaceuticals America, INC. | $16.24 | 2022 | |
| Hologic Sales and Service, LLC | $15.83 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $14.66 | 2021 | |
| Shire North American Group INC | $12.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelli Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.